Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 141 - 160 of 454 trials
Titlesort icon Investigator Disease(s)
A Phase IB Study of SAR650984 with Lenalidomide and Dexamethasone to Treat Recurrent or Persistent Multiple Myeloma
[Protocol 13-006]
Lendvai, Nikoletta
  • Hematology
    • Multiple Myeloma
A Phase IB Study of SGN-75 plus Everolimus in Patients with CD70-Positive Metastatic Renal Cell Cancer
[Protocol 12-263]
Molina, Ana Maria
  • Kidney Cancer
A Phase Ib Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer Who Previously Received Trastuzumab
[Protocol 09-093]
Modi, Shanu
  • Breast Cancer
A Phase IB Study of Vismodegib in Patients with Liver Cancer with Varying Degrees of Kidney and Liver Function
[Protocol 12-031]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase IB/II Study Evaluating Doxorubicin with or without a IMC-3G3 to Treat Advanced Soft-Tissue Sarcoma
[Protocol 10-156]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase IB/II study of E7080 plus Everolimus in Patients with Unresectable Advanced/Metastatic Renal Cell Carcinoma
[Protocol 10-084]
Molina, Ana Maria
  • Kidney Cancer
A Phase Ib/II Study of Gemcitabine and Docetaxel Plus Pazopanib for the Neoadjuvant (Presurgical) Treatment of Soft-Tissue Sarcoma
[Protocol 11-104]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase IB/II Study of OMP-59R5 with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-234]
O'Reilly, Eileen
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase IB/IIA Study of ABT-888 in Combination with Bendamustine with or without Rituximab in Patients with Lymphoma, Multiple Myeloma, and Solid Tumors
[Protocol 10-174]
Gerecitano, John
  • Hematology
    • Multiple Myeloma
  • Lymphoma
A Phase IB/IIA Study of Romidepsin plus Lenalidomide in Adults with Relapsed or Refractory Lymphoma and Myeloma
[Protocol 12-170]
Horwitz, Steven
  • Hematology
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Low-Risk Prostate Cancer
[Protocol 11-056]
Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111]
Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
  • Lung Cancer, Small Cell
    • Other
A Phase II Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094]
Wu, Abraham
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Abiraterone, Exemestane, or Both in Postmenopausal Women with ER-Positive Metastatic Breast Cancer
[Protocol 12-140]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187]
Scher, Howard
  • Prostate Cancer
    • Rising PSA After Primary Therapy
A Phase II Study of Abraxane with or without Tigatuzumab in Patients with Metastatic Triple-Negative Breast Cancer
[Protocol 11-082]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Adjuvant Bevacizumab, Metronomic Chemotherapy, Diet, and Exercise After Preoperative Chemotherapy for Breast Cancer
[Protocol 11-063]
Dickler, Maura
  • Breast Cancer
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer